Stephan Schmidt

6.3k total citations · 2 hit papers
176 papers, 4.4k citations indexed

About

Stephan Schmidt is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stephan Schmidt has authored 176 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmacology, 35 papers in Molecular Biology and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephan Schmidt's work include Antibiotics Pharmacokinetics and Efficacy (32 papers), Pharmacogenetics and Drug Metabolism (26 papers) and Pharmaceutical studies and practices (18 papers). Stephan Schmidt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (32 papers), Pharmacogenetics and Drug Metabolism (26 papers) and Pharmaceutical studies and practices (18 papers). Stephan Schmidt collaborates with scholars based in United States, Germany and Canada. Stephan Schmidt's co-authors include Hartmut Derendorf, Steffen Neumann, Matthias Müller‐Hannemann, Sebastian I. Wolf, Daniel González, LJ Lesko, Nadine Strehmel, Dierk Scheel, Christoph Böttcher and April Barbour and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Neurology.

In The Last Decade

Stephan Schmidt

162 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In silico fragmentation for computer assisted identification of metabolite mass spectra

2010 525 citations Stephan Schmidt et al. profile →
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare

2024 124 citations Stephan Schmidt et al. Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephan Schmidt United States	32	1.3k	876	505	503	488	176	4.4k
Momir Mikov Serbia	39	1.4k 1.1×	660 0.8×	242 0.5×	163 0.3×	365 0.7×	263	5.1k
Kang Ning China	46	4.2k 3.1×	314 0.4×	845 1.7×	416 0.8×	462 0.9×	376	7.9k
Vishal S. Vaidya United States	48	2.1k 1.6×	364 0.4×	267 0.5×	134 0.3×	631 1.3×	104	8.8k
Joo‐Youn Cho South Korea	40	1.6k 1.2×	494 0.6×	120 0.2×	535 1.1×	1.1k 2.2×	289	5.8k
Kelvin Chan Hong Kong	47	2.6k 2.0×	861 1.0×	1.6k 3.1×	145 0.3×	1.5k 3.2×	138	7.6k
Beom-Soo Han South Korea	20	3.5k 2.6×	291 0.3×	384 0.8×	163 0.3×	272 0.6×	50	5.6k
Philippe Hubert Belgium	42	1.2k 0.9×	596 0.7×	348 0.7×	190 0.4×	130 0.3×	306	7.3k
Xinyuan Zhang United States	35	1.2k 0.9×	244 0.3×	111 0.2×	153 0.3×	495 1.0×	127	3.5k
Avraham Yacobi United States	32	1.3k 1.0×	1.2k 1.3×	140 0.3×	322 0.6×	907 1.9×	128	6.0k
Chi Chen United States	57	5.8k 4.3×	467 0.5×	790 1.6×	680 1.4×	944 1.9×	315	12.5k

Countries citing papers authored by Stephan Schmidt

Since Specialization

Citations

This map shows the geographic impact of Stephan Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Schmidt more than expected).

Fields of papers citing papers by Stephan Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Schmidt. The network helps show where Stephan Schmidt may publish in the future.

Co-authorship network of co-authors of Stephan Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Schmidt. A scholar is included among the top collaborators of Stephan Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Schmidt. Stephan Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zhihong, Christopher J. Long, Christopher W. McAleer, et al.. (2025). Translation of a Human‐Based Malaria‐on‐a‐Chip Phenotypic Disease Model for In Vivo Applications. Advanced Science. 12(38). e05206–e05206.

Choi, Jaeyoung, M.-C. Calvet, Carl J. Pepine, et al.. (2025). High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(11). 729–740.

Cicali, Brian, et al.. (2025). Establishing a Quantitative Framework for Combined Oral Contraceptives: Evaluating the Impact of Drug–Drug Interactions on Exposure and Clinical (Surrogate) Efficacy Endpoints. The Journal of Clinical Pharmacology. 65(12). 1855–1863.

Guinn, Daphne, et al.. (2025). Application of Lactation Physiologically Based Pharmacokinetic Modeling to Predict Milk Exposure of Passively Diffused Drugs. The Journal of Clinical Pharmacology. 65(12). 1637–1649.

Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2025). Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care Settings. Journal of the American Medical Directors Association. 26(4). 105522–105522.

Wei, Yu‐Jung Jenny, Almut G. Winterstein, Siegfried Schmidt, et al.. (2024). Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer’s disease and related dementia. Age and Ageing. 53(3). 1 indexed citations

Schmidt, Stephan, Holger Hoffmann, Leif‐Alexander Garbe, et al.. (2024). Re-assessment of monoclonal antibodies against diclofenac for their application in the analysis of environmental waters. Analytical Methods. 16(21). 3349–3363. 1 indexed citations

Guzy, Serge, et al.. (2024). Development of breakthrough bleeding model of combined‐oral contraceptives utilizing model‐based meta‐analysis. CPT Pharmacometrics & Systems Pharmacology. 13(11). 2016–2025.

Costa, A., Won-Ho Kang, Cristiane Masetto de Gaitani, et al.. (2024). Redefining Statin Dosage Post‐Gastric Bypass: Insights from a Population Pharmacokinetics–Pharmacodynamics Link Approach. The Journal of Clinical Pharmacology. 64(12). 1473–1483. 1 indexed citations

10.

Vozmediano, Valvanera, et al.. (2023). Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of Gestation. The Journal of Clinical Pharmacology. 64(3). 312–322. 1 indexed citations

11.

Schmidt, Stephan, Valvanera Vozmediano, Rodrigo Cristofoletti, et al.. (2023). Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians. CPT Pharmacometrics & Systems Pharmacology. 12(7). 883–888. 4 indexed citations

12.

Wang, Grace Hsin‐Min, et al.. (2023). Modifiable statin characteristics associated with potential statin‐related prescribing cascades. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(12). 1307–1316. 1 indexed citations

13.

Peletier, L. A., et al.. (2023). The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies. CPT Pharmacometrics & Systems Pharmacology. 12(5). 639–655. 4 indexed citations

14.

Vouri, Scott Martin, et al.. (2023). High‐throughput screening for prescribing cascades among real world statin initiators. Pharmacoepidemiology and Drug Safety. 32(7). 773–782. 4 indexed citations

15.

Michelet, Robin, Jens Markus Borghardt, Teresa Dalla Costa, et al.. (2023). Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT Pharmacometrics & Systems Pharmacology. 12(6). 743–747. 7 indexed citations

16.

Moreira, Fernanda de Lima, et al.. (2022). Assessing the contribution of UGT isoforms on raltegravir drug disposition through PBPK modeling. European Journal of Pharmaceutical Sciences. 179. 106309–106309. 2 indexed citations

17.

Long, Tao, Galina Bernstein, Pierre Martineau, et al.. (2021). Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation. Pharmaceutics. 13(6). 849–849. 4 indexed citations

18.

Jiang, Sibo, Tanay S. Samant, Chakradhar V. Lagishetty, et al.. (2019). Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children. The Journal of Clinical Pharmacology. 60(5). 595–604. 3 indexed citations

19.

Brill, Margreke J. E., Aletta P. I. Houwink, Stephan Schmidt, et al.. (2013). Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. Journal of Antimicrobial Chemotherapy. 69(3). 715–723. 102 indexed citations

20.

Schmidt, Stephan, et al.. (2005). Community-Management in Unternehmen mit Wiki- und Weblogtechnologien. Qucosa (Saxon State and University Library Dresden). 105–120.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact